Erste Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Erste Asset Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-66,300	Closed	-$2.59M	–	596
2023 Q2	$2.59M	Hold	66,300	–	–	0.05%	256
2023 Q1	$1.58M	Buy	66,300 +14,300	+28%	+$313K	0.03%	303
2022 Q4	$1.09M	Buy	52,000 +27,000	+108%	+$576K	0.02%	347
2022 Q3	$433K	Hold	25,000	–	–	0.01%	438
2022 Q2	$242K	Hold	25,000	–	–	0.01%	498
2022 Q1	$408K	Buy	+25,000	New	+$369K	0.01%	456

Erste Asset Management's ISEE Position: Q3 2023 in Review

Erste Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 66,300 shares — an estimated $2.59M sold.

Erste Asset Management first reported a position in ISEE in Q1 2022 and held it in 6 quarters. The position peaked at $2.59M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Erste Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Erste Asset Management sold 66,300 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $2.59M.
Erste Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
Erste Asset Management's IVERIC bio, Inc. Common Stock position peaked at $2.59M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Erste Asset Management's 13F filing for Q3 2023, filed 26 Nov 2024.